Hybrid Conferencee

International Conference on Pathogen Biology, Vaccines and Immunology (ICPBVI - 27)

5th - 6th May 2027 | Utrecht, Netherlands
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Programme

Tentative Conference Agenda

Explore the proposed two-day programme developed around the conference Session Tracks and aligned United Nations Sustainable Development Goals.

Conference Format Hybrid Conference In-person and virtual participation
Programme 2 Days 5–6 May 2027
Academic Scope 11 Tracks Conference Session Tracks
Research Scope 20 Areas Call for Papers themes
SDG Alignment 7 SDGs SDGs 3, 4, 9, 10, 12, 16 and 17
Tentative Agenda & Timings

Session timings, sequence, track grouping and allocations are tentative and subject to change. Final timings will be confirmed closer to the conference. All timings follow the local time of the conference location.

Day 01

Opening, Keynote & Technical Sessions

5 MAY 2027 HYBRID
  1. 09:00 AM 09:30 AM

    Registration, Welcome Kit Collection & Virtual Check-in

    Participant arrival, credential verification and virtual lobby access.

    HYBRID
  2. 09:30 AM 09:45 AM

    Networking Tea & Digital Welcome

    Informal networking for on-site and virtual participants.

    HYBRID
  3. 09:45 AM 10:30 AM

    Welcome Address, Opening Plenary & Keynote Presentation I

    Opening of the conference and introduction to its research focus.

    PLENARY
  4. 10:30 AM 12:30 PM

    Concurrent Technical Session I

    3 TRACKS
    Track 01
    Molecular Mechanisms of Pathogen Biology
    34
    Track Overview

    This track focuses on the intricate molecular interactions between pathogens and host cells. Understanding these mechanisms is crucial for developing targeted therapeutic strategies.

    Track 02
    Innovations in Vaccine Development
    39
    Track Overview

    This session will explore the latest advancements in vaccine technology, including novel adjuvants and delivery systems. Emphasis will be placed on the rapid development of vaccines in response to emerging infectious diseases.

    Track 03
    Immunological Responses to Infectious Agents
    39
    Track Overview

    This track examines the immune responses elicited by various infectious agents, highlighting both innate and adaptive immunity. Insights gained will aid in the design of effective vaccines and immunotherapies.

  5. 12:30 PM 01:30 PM

    Lunch & Networking Break

    Refreshment interval and networking opportunity.

    BREAK
  6. 01:30 PM 03:30 PM

    Concurrent Technical Session II

    3 TRACKS
    Track 04
    Epidemiology of Infectious Diseases
    317
    Track Overview

    This session will delve into the epidemiological trends and patterns of infectious diseases globally. Discussions will include risk factors, transmission dynamics, and the impact of public health interventions.

    Track 05
    Clinical Research in Infectious Diseases
    39
    Track Overview

    This track will present cutting-edge clinical research findings related to the diagnosis, treatment, and management of infectious diseases. Emphasis will be placed on translational research and its implications for patient care.

    Track 06
    Outbreak Management and Response Strategies
    316
    Track Overview

    This session will focus on effective strategies for managing infectious disease outbreaks, including surveillance, containment, and communication. Case studies will provide insights into successful outbreak responses.

  7. 03:30 PM 04:00 PM

    Interactive Q&A, Day 1 Summary & Group Photo

    Closing interaction and key takeaways from the first day.

    CLOSING
Day 02

Keynote, Technical Sessions & Awards

6 MAY 2027 HYBRID
  1. 09:00 AM 09:15 AM

    Participant Check-in & Day 2 Welcome

    On-site attendance confirmation and virtual lobby access.

    HYBRID
  2. 09:15 AM 10:00 AM

    Keynote Presentation II

    Expert address on the future of the conference research domain.

    PLENARY
  3. 10:00 AM 12:00 PM

    Concurrent Technical Session III

    3 TRACKS
    Track 07
    Vaccine Safety and Efficacy
    316
    Track Overview

    This track will address critical issues surrounding vaccine safety and efficacy, including adverse events and long-term outcomes. Discussions will aim to enhance public trust in vaccination programs.

    Track 08
    Pathogen Evolution and Resistance
    312
    Track Overview

    This session will explore the evolutionary dynamics of pathogens and the emergence of antimicrobial resistance. Understanding these trends is essential for developing effective control measures.

    Track 09
    Immunotherapy for Infectious Diseases
    39
    Track Overview

    This track will investigate the role of immunotherapy in the treatment of infectious diseases, including monoclonal antibodies and immune checkpoint inhibitors. The potential for harnessing the immune system to combat infections will be emphasized.

  4. 12:00 PM 01:00 PM

    Lunch & Networking Break

    Refreshment interval and professional networking.

    BREAK
  5. 01:00 PM 03:00 PM

    Concurrent Technical Session IV

    2 TRACKS
    Track 10
    Global Health Perspectives on Infectious Diseases
    310
    Track Overview

    This session will provide a global perspective on the burden of infectious diseases and the challenges faced in different regions. Discussions will include health disparities and the role of international collaboration in disease control.

    Track 11
    Future Directions in Immunology Research
    39
    Track Overview

    This track will highlight emerging trends and future directions in immunology research related to infectious diseases. Topics will include novel therapeutic approaches and the integration of technology in immunological studies.

  6. 03:00 PM 03:30 PM

    Publications, Best Paper & Best Presentation Awards

    Publication guidance and recognition of outstanding research contributions.

    AWARDS
  7. 03:30 PM 04:00 PM

    Valedictory Session, Closing Remarks & Group Photo

    Conference summary, acknowledgements and formal conclusion.

    CLOSING
Aligned SDGs
3 Good Health and Well-being 4 Quality Education 9 Industry, Innovation and Infrastructure 10 Reduced Inequalities 12 Responsible Consumption and Production 16 Peace, Justice and Strong Institutions 17 Partnerships for the Goals

Be Part of ICPBVI-27

Submit your research or complete your conference registration.